C. Zamagni
- Co-authors
- Stefania ZambelliGiuseppe VialeEva CiruelosMarco ColleoniLucia Del MastroGabriella MarianiPinuccia ValagussaDaniel Egle
- Topics
- Advanced Breast Cancer Therapies (3 papers)Breast Cancer Treatment Studies (3 papers)Cancer Genomics and Diagnostics (3 papers)
- Cited by
- OncologyCancer ResearchImmunology
In The Last Decade
C. Zamagni
13 papers receiving 313 citations
Hit Papers
Peers
Comparison fields: 5 of 41
- Oncology 264
- Cancer Research 121
- Pulmonary and Respiratory Medicine 72
- Immunology 67
- Molecular Biology 46
Countries citing papers authored by C. Zamagni
This map shows the geographic impact of C. Zamagni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Zamagni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Zamagni more than expected).
Fields of papers citing papers by C. Zamagni
This network shows the impact of papers produced by C. Zamagni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Zamagni. The network helps show where C. Zamagni may publish in the future.
Co-authorship network of co-authors of C. Zamagni
This figure shows the co-authorship network connecting the top 25 collaborators of C. Zamagni. A scholar is included among the top collaborators of C. Zamagni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Zamagni. C. Zamagni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized studybreakdown → | 204 |
| 6 | 41 | |
| 7 | 14 | |
| 8 | 1 | |
| 9 | 6 | |
| 10 | The addition of topotecan to carboplatin and paclitaxel as first-line therapy for advanced ovarian cancer; is it possible only with peripheral blood stem cell support? | 9 |
| 11 | Advanced ovarian cancer patients with no evidence of disease after platinum-based chemotherapy: retrospective analysis of the role of second-look. | 3 |
| 12 | Chemotherapy of advanced ovarian cancer. | 1 |
| 13 | 29 | |
| 14 | 6 |
About C. Zamagni
C. Zamagni is a scholar working on Reproductive Medicine, Cancer Research and Oncology, having authored 14 papers that have together received 319 indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (3 papers), Breast Cancer Treatment Studies (3 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Oncology (264 citations), Cancer Research (121 citations) and Immunology (67 citations). C. Zamagni has collaborated with scholars based in Italy, Spain and Germany. Frequent co-authors include Stefania Zambelli, Giuseppe Viale, Eva Ciruelos, Marco Colleoni, Lucia Del Mastro, Gabriella Mariani, Pinuccia Valagussa, Daniel Egle, Begoña Bermejo and A. Antón. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.